RT Journal Article SR Electronic T1 Detection of Salmonella Typhi bacteriophages in surface waters as a scalable approach to environmental surveillance JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2023.02.14.23285806 DO 10.1101/2023.02.14.23285806 A1 Shrestha, Sneha A1 Da Silva, Kesia Esther A1 Shakya, Jivan A1 Yu, Alexander T. A1 Katuwal, Nishan A1 Shrestha, Rajeev A1 Shakya, Mudita A1 Shahi, Sabin Bikram A1 Naga, Shiva Ram A1 LeBoa, Christopher A1 Aiemjoy, Kristen A1 Bogoch, Isaac I. A1 Saha, Senjuti A1 Tamrakar, Dipesh A1 Andrews, Jason R. YR 2023 UL http://medrxiv.org/content/early/2023/02/17/2023.02.14.23285806.abstract AB Environmental surveillance, using detection of Salmonella Typhi DNA, has emerged as a potentially useful tool to identify typhoid-endemic settings; however, it is relatively costly and requires molecular diagnostic capacity. We sought to determine whether S. Typhi bacteriophages are abundant in water sources in a typhoid-endemic setting, using low-cost assays. We collected drinking and surface water samples from urban, peri-urban and rural areas in 4 regions of Nepal. We performed a double agar overlay with S. Typhi to assess the presence of bacteriophages. We isolated and tested phages against multiple strains to assess their host range. We performed whole genome sequencing of isolated phages, and generated phylogenies using conserved genes. S. Typhi-specific bacteriophages were detected in 54.9% (198/361) of river water samples and 6.3% (1/16) drinking water samples from the Kathmandu Valley and Kavrepalanchok. Water samples collected within or downstream of population-dense areas were more likely to be positive (72.6%, 193/266) than those collected upstream from population centers (5.3%, 5/95) (p=0.005). In urban Biratnagar and rural Dolakha, where typhoid incidence is low, only 6.7% (1/15, Biratnagar) and 0% (0/16, Dolakha) samples contained phages. All S. Typhi phages were unable to infect other Salmonella and non-Salmonella strains, nor a Vi-knockout S. Typhi strain. Representative strains from S. Typhi lineages were variably susceptible to the isolated phages. Phylogenetic analysis showed that S. Typhi phages belonged to two different viral families (Autographiviridae and Siphoviridae) and clustered in three distinct groups. S. Typhi bacteriophages were highly abundant in surface waters of typhoid-endemic communities but rarely detected in low typhoid burden communities. Bacteriophages recovered were specific for S. Typhi and required Vi polysaccharide for infection. Screening small volumes of water with simple, low-cost plaque assays enables detection of S. Typhi phages and should be further evaluated as a scalable tool for typhoid environmental surveillance.HighlightsTyphoid phages are detectable in surface water using simple assays, in communities with high typhoid burden.Bacteriophages are highly specific for S. Typhi and required Vi polysaccharide for infection.S. Typhi phages have a broad lytic activity against the S. Typhi strains circulating in Nepal.Phage plaque assay can be used as a low-cost tool to identify communities where typhoid is endemic.The high abundance of phages in river water suggest that this could be an alternative to molecular methods for environmental surveillance for typhoid.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Bill & Melinda Gates Foundation, Seattle, WA [grant number OPP1217093].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript